Quarterly report · Q3
4578.TEDINET S100PGE4
Period2022-01-01 → 2022-09-30
Filed2022-11-02
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.27T | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥451.8bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥1.50T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.11T | 2021-01-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥388.6bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥114.8bn | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥47.7bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥158.1bn | 2021-01-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥47.0bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥146.0bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥53.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥163.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥166.3bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥47.1bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥111.0bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥41.3bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥125.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥126.6bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥35.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥113.9bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.4bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥130.0bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥36.3bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥3.19T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥2.82T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.82T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥853.3bn | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥775.7bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.33T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.02T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.88T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.30T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.01T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.98T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥477.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥448.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥356.9bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥171.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥228.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥197.2bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥60.4bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥95.3bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥33.0bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥84.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.8bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥83.7bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥204.65 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥76.06 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥231.32 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥233.5 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥64.97 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥204.63 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥76.04 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥231.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥233.34 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥64.8 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.3% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 70.5% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥126.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-07-01 → 2022-09-30 | ¥43.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥94.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-07-01 → 2022-09-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥31.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥11.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥9.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥32.0bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥11.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥32.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥11.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥34.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥12.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥27.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥10.3bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥27.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥10.3bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥12m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥3.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥325.6bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥119.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥325.6bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥119.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥7m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥49.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥819.3bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥290.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥819.3bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥290.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥84.5bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥32.3bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥1.30T |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥463.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥1.27T |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥451.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥32.0bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥11.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥149.7bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥59.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥110.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-07-01 → 2021-09-30 | ¥36.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥82.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-07-01 → 2021-09-30 | ¥26.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥28.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥10.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | ¥12.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-07-01 → 2021-09-30 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥28.5bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥10.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥28.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥10.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥33.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥11.8bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥24.1bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥8.9bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥24.1bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥8.9bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥17m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥8m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥5.8bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥2.5bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥280.1bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥104.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥280.0bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥104.7bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥33m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥12m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥45.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥19.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥721.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥248.5bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥721.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥248.5bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥128.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥34.5bn |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥1.14T |
| —segment total | revenue | 2021-07-01 → 2021-09-30 | ¥399.0bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥1.11T |
| —segment total | revenue external | 2021-07-01 → 2021-09-30 | ¥388.6bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥28.5bn |
| —segment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥10.4bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥191.8bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥58.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 835
| Item | Context | Value | Unit |
|---|---|---|---|
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長兼CEO 樋口 達夫 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区神田司町二丁目９番地（同所は登記上の所在地であり、実際の業務は下記の最寄りの連絡場所で行っております。） | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03－6717－1410 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務会計部長 新井 敏文 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区港南二丁目16番４号 品川グランドセントラルタワー12階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03－6717－1410 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務会計部長 新井 敏文 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E21183 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45780 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)大塚ホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Otsuka Holdings Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-01-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所（プライム市場） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。当社の単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |